Homburger advised Goldman Sachs International in connection with the issuance of CHF 100 m Senior Secured Notes by Matterhorn Telecom S.A.
On July 21, 2023, Matterhorn Telecom S.A., the parent company of Salt Mobile SA, issued CHF 100 m 5.250% Senior Secured Notes due 2028 guaranteed by Matterhorn Telecom Holding S.A. and Salt Mobile SA. Goldman Sachs International acted as Global Coordinator and Sole Bookrunner.
Homburger advised GAM on the carve-out of its third party fund management services
On June 29, 2023, GAM Holding AG announced the sale of its third party fund services (“FMS Businesses”) in Luxembourg and Switzerland to Carne Group (“the Transactions”).
Homburger advised Qubit Investments on the sale of its stake in Flisom AG
On June 29, 2023, the sale of a majority shareholding in Flisom AG has been successfully completed. Qubit Investments Pte Ltd,
Homburger advised Santhera on its reverse share split
On July 3, 2023, Santhera Pharmaceuticals Holding AG (SIX: SANN) completed a 10:1 reverse split of its shares,
Homburger advises Migros on the reorganization of its supermarket business
On June 29, 2023, Migros, a cooperative union active in the retail space and Switzerland’s largest employer,
Homburger advises U.S. Cotton on the sale of FLAWA Consumer GmbH in a management buy-out
As part of a strategic reorganization, the American cotton manufacturer U.S. Cotton, LLC, has sold the Flawil-based producer of absorbent cotton and other products, FLAWA Consumer GmbH, to members of its management.
Homburger advises Nice & Green SA on the renegotiation of its investment in an equity-linked convertible notes debt instrument issued by Evolva Holding SA
On June 26, 2023, Evolva Holding SA announced that it had entered into a new agreement with Nice & Green SA (N&G) to replace an existing an equity-linked debt instrument issued by Evolva consisting of convertible notes issued in several tranches to be drawn against issuance of convertible notes.
Homburger advised Santhera on its exclusive North America license for vamorolone to Catalyst
On June 20, 2023, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced the grant of an exclusive North America license for vamorolone to Catalyst Pharmaceuticals,
Homburger advised Bunge on its business combination with Viterra
On June 13, 2023, Bunge Limited (NYSE: BG) («Bunge») announced it has entered into a definitive agreement with Viterra Limited,
Homburger advised Zürcher Kantonalbank on the issuance of its EUR 500 m Bail-in Bonds
On June 8, 2023, Zürcher Kantonalbank successfully completed its inaugural EUR Bail-in Bond issuance in the amount of EUR 500 m.